BI-732, a novel fourth-generation EGFR-TKI, demonstrates promising activities against the C797S-mediated EGFRTKI resistance

CANCER RESEARCH(2023)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要